Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 71610-868

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 71610-868). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0868 60)

Lisinopril HCTZ USP tablets label showing 20/12.5 mg strength in a package of 90 tablets. The label includes the NDC number 71510-868-60 and manufacturer information: Zhejiang Huahua Pharmaceuticals Co., Ltd., Xunqiao, China, with packaging by Aphena Pharma, Cookeville, TN. Instructions for storage and dispensing are also present.*

FDA Label Image

Aphena (Aphena)

FDA Label Image

Chemical Structure (Lisinopril)

Chemical structure diagram of Lisinopril and Hydrochlorothiazide. The image depicts the molecular arrangement with labeled atoms and bonds, including hydrate molecules (2H2O).*

FDA Label Image

Chemical Structure (HCTZ)

Chemical structure of Lisinopril and Hydrochlorothiazide, depicting the molecular arrangement of atoms and bonds characteristic to these active ingredients in tablet form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.